Corner is pioneering a new class of immunotherapies. Our versatile dendritic cell hyperactivation (hDC) platform is unique in its ability to address a virtually unbounded range of cancers and infectious diseases. Our platform technology induces exceptional memory T cell responses that provide robust and durable immunity. Corner seeks to transform standard of care, ushering in a new era of robust, rapid, patient-friendly and low-cost immunotherapies – even for the most difficult to treat diseases.
Company Details
- Employees
- 36
- Founded
- -
- Address
- 500 N Beacon St, Watertown,massachusetts 02472,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://cornertx.com/
- HQ
- Watertown, Massachusetts
Corner Therapeutics Questions
Corner Therapeutics's website is https://cornertx.com/
Corner Therapeutics's LinkedIn profile is https://www.linkedin.com/company/corner-therapeutics
Corner Therapeutics has
36 employees.
View email and phone details for 36
employees at Corner Therapeutics.
Corner Therapeutics's industry is
Biotechnology Research
Corner Therapeutics's top competitors are
Vertex Pharmaceuticals,
Beam Therapeutics,
Landmark Bio,
Entrada Therapeutics,
Korro Bio, Inc.,
Kisbee Therapeutics,
Verve Therapeutics,
Kojin Therapeutics,
Tessera Therapeutics,
Akita Biosciences.
Corner Therapeutics's categories are Biotechnology Research
Corner Therapeutics's founding year is 2020
